GTS Securities’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

GTS Securities’s Portfolio NURO Stock Details NURO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-25,000	Closed	-$111K	–	1705
2025 Q1	$111K	Buy	25,000 +2,241	+10%	+$9.61K	﹤0.01%	1175
2024 Q4	$90.4K	Buy	+22,759	New	+$92.2K	﹤0.01%	1171

GTS Securities's NURO Position: Q2 2025 in Review

GTS Securities sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q2 2025, closing a stake of 25,000 shares — an estimated $111K sold.

GTS Securities first reported a position in NURO in Q4 2024 and held it in 2 quarters. The position peaked at $111K in Q1 2025. 0 funds tracked by Wall St. Rank hold NURO as of Q2 2025.

GTS Securities reported no remaining NeuroMetrix, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
GTS Securities sold 25,000 NeuroMetrix, Inc. Common Stock shares in Q2 2025, an estimated $111K.
GTS Securities first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2024 and held it in 2 quarters.
GTS Securities's NeuroMetrix, Inc. Common Stock position peaked at $111K in Q1 2025.
0 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q2 2025.

Based on GTS Securities's 13F filing for Q2 2025, filed 8 Aug 2025.